SEARCH

SEARCH BY CITATION

References

  • Andrew N. C. and Faller D. V. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499.
  • Christensen M. A., Zhou W., Qing H. et al. (2004) Trancriptional regulation of BACE1, the β-amyloid precursor protein β-secretase, by Sp1. Mol. Cell Biol. 24, 865874.
  • Eckert A., Marques C. A., Keil U. et al. (2003) Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann. NY Acad. Sci. 1010, 604609.DOI: 10.1196/annals.1299.113
  • Floyd R. A. and Hensley K. (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795807.DOI: 10.1016/S0197-4580(02)00019-2
  • Fukumoto H., Cheung B. S., Hyman B. T. et al. (2002) β-Secretase protein and activity are increased in neocortex in Alzheimer disease. Arch. Neurol. 59, 13811389.DOI: 10.1001/archneur.59.9.1381
  • Giovanni A., Keramaris E., Morris E. J. et al. (2000) E2F1 mediates death of beta-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275, 11 55311 560.
  • Harkany T., Abraham I., Nyakas C. et al. (2000) Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy. Rev. Neurosci. 11, 329382.
  • Holsinger R. M. D., McLean C. A., Beyreuther K. et al. (2002) Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol. 51, 783786.
  • Hong H. S., Hwang E. M., Sim H. J. et al. (2003) Interferon γ stimulates β-secretase expression and sAPPβ production in astrocytes. Biochem. Biophys. Res. Commun. 307, 922927.
  • Hussain I., Powell D., Howlett D. R. et al. (1999) Identification of a novel aspartic protease (Asp-2) as beta-secretase. Mol. Cell Neurosci. 14, 419427.
  • Iversen L. L., Mortishire-Smith R. J., Pollack S. J. et al. (1995) The toxicity in vitro of beta-amyloid protein. Biochem. J. 311, 116.
  • Kaltschmidt B., Uherek M., Wellmann H. et al. (1999) Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis. Proc. Natl Acad. Sci. USA 96, 94099414.
  • Kao S.-C., Krichevsky A. M., Kosik K. S. et al. (2004) BACE 1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem. 279, 19421949.
  • Koistinaho M., Kettunen M. I., Goldstein G. et al. (2002) Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ishemic vulnerability: role of inflammation. Proc. Natl Acad. Sci. USA 99, 16101615.
  • Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227, 680685.
  • Le Niculescu H., Bonfoco E., Kasuya Y. et al. (1999) Withdrawal of survival factors results in activation of the JNKs pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell Biol. 19, 751763.
  • Lin X., Koelsch G., Wu S. et al. (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl Acad. Sci. USA 97, 14561460.
  • Madamanchi N. R., Li S., Patterson C. et al. (2001) Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler. Thromb. Vasc. Biol. 21, 321326.
  • Mattwes D. E. and Farewell V. T. (1988) Using and Understanding Medical Statistics, 2nd ed., rev. Karger, Basel.
  • McDonald D. R., Bamberger M. E., Combs C. K. et al. (1998) Beta-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18, 44514460.
  • Mielke K. and Herdegen T. (2000) JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 61, 4560.
  • Misonou H., Morishima-Kawashima M. and Ihara Y. (2000) Oxidative stress induces intracellular accumulation of amyloid β-protein (Aβ) in human neuroblastoma cells. Biochemistry 39, 69516959.
  • Nakashima I., Liu W., Akhand A. A. et al. (2003) 4-Hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions. Mol. Aspects Med. 24, 231238.
  • Nunomura A., Perry G., Aliev G. et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759767.
  • Paola D., Domenicotti C., Nitti P. et al. (2000) Oxidative stress induces increase in intracellular amyloid β-protein production and selective activation of βI and βII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268, 642646.
  • Perry G., Castellani R. J., Hirai K. et al. (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimer's Dis. 1, 4555.
  • Perry G., Nunomura A., Hirai K. et al. (2000a) Oxidative damage in Alzheimer's disease: the metabolic dimension. Int. J. Dev. Neurosci. 18, 417421.
  • Perry G., Raina A. K., Nunomura A. et al. (2000b) How important is oxidative damage? Lessons from Alzheimer's disease. Free Radical Biol. Med. 28, 831834.
  • Savage M. J., Lin Y. G., Ciallella J. R. et al. (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22, 33763385.
  • Sayre L. M., Zelasko D. A., Harris P. L. R. et al. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 20922097.
  • Selkoe D. J. (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. NY Acad. Sci. 924, 1725.
  • Selkoe D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741766.
  • Sinha S., Anderson J. P., Barbour R. et al. (1999) Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537540.
  • Smith M. A., Hirai H., Hsiao K. et al. (1998) Amyloid-β deposition in Alzheimer's transgenic mice is associated with oxidative stress. J. Neurochem. 70, 22122215.
  • Takeda A., Smith M. A., Avilà J. et al. (2000) In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75, 12341241.
  • Tamagno E., Bardini P., Obbili A. et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279288.
  • Tamagno E., Guglielmotto M., Bardini P. et al. (2003a) Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress. Neurobiol. Dis. 14, 291301.
  • Tamagno E., Parola M., Guglielmotto M. et al. (2003b) Multiple signaling events in amyloid β-induced, oxidative stress dependent neuronal apoptosis. Free Radical Biol. Med. 35, 4558.
  • Vassar R., Bennett B. D., Babu-Khan S. et al. (1999) β Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Wang D.-S., Iwata N., Hama E. et al. (2003) Oxidized neprilysin in aging and Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 310, 236241.
  • Wang X., Martindale J. L., Liu Y. et al. (1998) The cellular response to oxidative stress: influences of mitogen activated protein kinase signaling pathways on cell survival. Biochem. J. 333, 291300.
  • Yan R., Bienkowski M. J., Shuck M. E. et al. (1999) Membrane anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533537.
  • Yang L.-B., Lindholm R., Yan R. et al. (2003) Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 34.
  • Zhu X., Rottkamp C. A., Boux H. et al. (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59, 880888.
  • Zhu X., Castellani R. J., Takeda A. et al. (2001a) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer: the ‘two hit’ hypothesis. Mech. Ageing Dev. 123, 3946.
  • Zhu X., Raina A. K., Rottkamp C. A. et al. (2001b) Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435441.
  • Zhu X., Rottkamp C. A., Hartzler A. et al. (2001c) Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J. Neurochem. 79, 311318.
  • Zhu X., Ogawa O., Wang Y. et al. (2003a) JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease. J. Neurochem. 85, 8793.
  • Zhu X., Raina A. K., Lee H. G. et al. (2003b) Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxid. Redox Signal. 5, 571576.